LRSAM1

Chr 9ADAR

leucine rich repeat and sterile alpha motif containing 1

Also known as: CMT2P, RIFLE, TAL

The protein functions as an E3 ubiquitin-protein ligase that regulates cargo sorting during endocytosis and serves as a bacterial recognition protein that promotes autophagy-mediated clearance of intracellular pathogens. Mutations cause Charcot-Marie-Tooth disease, axonal type 2P, a peripheral neuropathy that can be inherited in either autosomal dominant or autosomal recessive patterns. This gene is not highly constrained against loss-of-function variants (LOEUF 0.754).

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismAD/ARLOEUF 0.751 OMIM phenotype
Clinical SummaryLRSAM1
🧬
Gene-Disease Validity (ClinGen)
Charcot-Marie-Tooth disease axonal type 2P · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
48 unique Pathogenic / Likely Pathogenic· 222 VUS of 500 total submissions
📖
GeneReview available — LRSAM1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.75LOEUF
pLI 0.000
Z-score 3.00
OE 0.55 (0.410.75)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.41Z-score
OE missense 0.94 (0.871.03)
399 obs / 422.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.55 (0.410.75)
00.351.4
Missense OE0.94 (0.871.03)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 29 / 52.4Missense obs/exp: 399 / 422.6Syn Z: -0.48
DN
0.7131th %ile
GOF
0.72top 25%
LOF
0.2679th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports dominant-negative. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median · 1 literature citation
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNMoreover, in conjunction with other data in the literature, our results support a model, by which disruption of the C-terminal RING domain confers dominant negative properties to LRSAM1.PMID:24894446

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic25
Likely Pathogenic23
VUS222
Likely Benign196
Benign17
Conflicting17
25
Pathogenic
23
Likely Pathogenic
222
VUS
196
Likely Benign
17
Benign
17
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
16
1
8
0
25
Likely Pathogenic
18
1
4
0
23
VUS
2
196
23
1
222
Likely Benign
0
0
109
87
196
Benign
0
0
17
0
17
Conflicting
17
Total3619816188500

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

LRSAM1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC